These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31186850)

  • 1. Hepatitis C viral infection in difficult-to-treat populations: An overview.
    Afdhal NH
    Clin Liver Dis (Hoboken); 2012 Jul; 1(3):63-64. PubMed ID: 31186850
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic overview of hepatitis C infection in the Middle East and North Africa.
    Chaabna K; Cheema S; Abraham A; Alrouh H; Lowenfels AB; Maisonneuve P; Mamtani R
    World J Gastroenterol; 2018 Jul; 24(27):3038-3054. PubMed ID: 30038471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of liver transplantation in viral hepatitis.
    Pons JA
    J Hepatol; 1995; 22(1 Suppl):146-53. PubMed ID: 7602069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative review of HLA associations with hepatitis B and C viral infections across global populations.
    Singh R; Kaul R; Kaul A; Khan K
    World J Gastroenterol; 2007 Mar; 13(12):1770-87. PubMed ID: 17465466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatitis C revolution part 2: difficult-to-treat groups and experimental approaches.
    Thiagarajan P; Ryder SD
    Curr Opin Infect Dis; 2015 Dec; 28(6):572-5. PubMed ID: 26524329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of hepatitis B viral replication and genetic variability.
    Tong S; Revill P
    J Hepatol; 2016 Apr; 64(1 Suppl):S4-S16. PubMed ID: 27084035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?
    Solitano V; Plaz Torres MC; Pugliese N; Aghemo A
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34205966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ledipasvir and sofosbuvir for treatment of post- renal transplant hepatitis C infection: A case report with review of literature.
    Jha R; Fatima R; Lakhtakia S; Jha A; Srikant P; Narayan G
    Indian J Nephrol; 2016; 26(3):216-9. PubMed ID: 27194839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of histology, viral load, and in situ viral detection in hepatic biopsies from patients with liver transplants secondary to hepatitis C infection.
    Nuovo GJ; Holly A; Wakely P; Frankel W
    Hum Pathol; 2002 Mar; 33(3):277-84. PubMed ID: 11979367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C.
    Havens JR; Schaninger T; Fraser H; Lofwall M; Staton M; Young AM; Hoven A; Walsh SL; Vickerman P
    BMJ Open; 2021 Jul; 11(7):e041490. PubMed ID: 34226208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HEP DART 2003: Frontiers in drug development for viral hepatitis.
    Raney AK; Hamatake RK; Hong Z
    Expert Opin Investig Drugs; 2004 Mar; 13(3):289-93. PubMed ID: 15013947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Which treatment options are validated for chronic viral hepatitis?].
    Höner zu Siederdissen C; Manns MP; Cornberg M
    Internist (Berl); 2013 Dec; 54(12):1427-8, 1430-3. PubMed ID: 24258199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of hepatitis C infection, molecular biology, and new treatment.
    Rabaan AA; Al-Ahmed SH; Bazzi AM; Alfouzan WA; Alsuliman SA; Aldrazi FA; Haque S
    J Infect Public Health; 2020 May; 13(5):773-783. PubMed ID: 31870632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of hepatitis C: perspectives.
    Pol S; Corouge M
    Med Mal Infect; 2014 Oct; 44(10):449-54. PubMed ID: 25174659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparing the patient for success: treat or wait?
    Buti M; Esteban R
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S332-6. PubMed ID: 24091112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future landscape of hepatitis C research - Basic, translational and clinical perspectives.
    Moradpour D; Grakoui A; Manns MP
    J Hepatol; 2016 Oct; 65(1 Suppl):S143-S155. PubMed ID: 27641984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma.
    D'souza S; Lau KC; Coffin CS; Patel TR
    World J Gastroenterol; 2020 Oct; 26(38):5759-5783. PubMed ID: 33132633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of hepatitis C in Europe: can WHO targets be achieved?
    Matičič M; Lombardi A; Mondelli MU; Colombo M;
    Clin Microbiol Infect; 2020 Jul; 26(7):818-823. PubMed ID: 31978546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of hepatitis C viral infection.
    Aoki H; Yamamoto T; Kajino K; Arakawa Y; Hino O
    Intervirology; 1996; 39(3):140-4. PubMed ID: 9058166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymalfasin for the treatment of chronic hepatitis C infection.
    Rustgi VK
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):885-92. PubMed ID: 16307501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.